Shaping the future of pathology

We deliver high‑quality laboratory and diagnostic services, performing more than 65 million tests every year. With a portfolio of over 6,000 assays, our accredited labs provide everything from routine blood tests to advanced molecular and genetic analysis – giving you fast, reliable answers when they matter most.

Explore

Our NHS Partnerships

Test database

Our database hosts almost 2,000 diagnostic tests. Use our user-friendly search feature for full user details including how to order tests, collect samples, and interpret results.

View

Research & Innovation

£0m+ invested in

employee-led innovation and research projects since 2022

1st urban drone deliveries

of pathology samples in the UK

0 hospital sites

supported to roll out Rapid Pathogen Metagenomics

News & resources

Microsoft global outage service update

We are aware of the Microsoft outage affecting organisations globally. Access to Outlook and other Microsoft platforms are affected, which means we are not able to send or receive emails. Our services are operating as normal, and results are being communicated via our usual systems. Thank you for your patience. We will continue to monitor [...]

Celebrating National Pathology Week

Comment by Mark Dollar, CEO, SYNLAB UK&I As an organisation at the forefront of healthcare science, SYNLAB UK & Ireland makes a meaningful difference every day to the health and wellbeing of the patients we serve. National Pathology Week is an annual celebration of the crucial contribution pathologists make to healthcare. I am immensely proud [...]

SYNLAB UK&I achieves Silver in Onvero’s 2026 TIDE benchmarking

SYNLAB UK&I is proud to share that we have achieved Silver in Onvero's 2026 Talent Inclusion and Diversity Evaluation (TIDE) benchmarking. TIDE is an external benchmarking framework which looks at how organisations approach inclusion across areas including leadership, recruitment, employee voice, wellbeing and belonging. Lauren Crawford, Head of Diversity, Equity & Inclusion at SYNLAB UK&I, said: [...]